PreprintCited by 24Neutrophil, Myeloperoxidase and Oxidative MechanismsImmunodeficiency and Autoimmune DisordersRedox biology and oxidative stress

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

EROS is a selective chaperone regulating the phagocyte NADPH oxidase and purinergic signalling

Open access

Preprint — published as 10.7554/elife.76387 · Paper page

Abstract

EROS (Essential for Reactive Oxygen Species) protein is indispensable for expression of gp91 phox , the catalytic core of the phagocyte NADPH oxidase. EROS deficiency in humans is a novel cause of the severe immunodeficiency, chronic granulomatous disease (CGD), but its mechanism of action was unknown until now. We elucidate the role of EROS, showing it acts at the earliest stages of gp91 phox maturation. It binds the immature 58kDa gp91 phox directly, preventing gp91 phox degradation and allowing glycosylation via the oligosaccharyltransferase (OST) machinery and the incorporation of the heme prosthetic groups essential for catalysis. EROS also regulates the purine receptors P2X7 and P2X1 through direct interactions and P2X7 is almost absent in EROS deficient mouse and human primary cells. Accordingly, lack of EROS results in markedly abnormal P2X7 signalling, inflammasome activation and T cell responses. The loss of both ROS and P2X7 signalling leads to resistance to influenza infection. Our work identifies EROS as a highly selective chaperone for key proteins in innate and adaptive immunity and a rheostat for immunity to infection. It has profound implications for our understanding of immune physiology, ROS dysregulation and possibly gene therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2021.09.14.460103

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 81

  1. 10.1038/353668a0 · DOI
  2. 10.1097/PAS.0b013e318297427d · DOI
  3. 2018, A homozygous loss-of-function mutation leading to CYBC1 deficiency causes chronic granulomatous disease, Nat Commun, 9, 4447, 10.1038/s41467-018-06964-x · DOI
  4. 10.1124/pr.113.008003 · DOI
  5. 10.1042/BJ20140555 · DOI
  6. 10.1074/jbc.M901255200 · DOI
  7. 2017, Engineering stability in Nadph oxidases: A common strategy for enzyme production, Mol Membr Biol, 34, 67, 10.1080/09687688.2018.1535141 · DOI
  8. 10.1089/ars.2010.3669 · DOI
  9. 10.1161/ATVBAHA.112.300361 · DOI
  10. 10.1016/j.ceb.2016.03.021 · DOI
  11. 10.1038/srep20946 · DOI
  12. 10.1186/s12974-015-0325-5 · DOI
  13. 10.1101/gr.2334104 · DOI
  14. 10.1073/pnas.1322831111 · DOI · Paper page
  15. 10.1038/srep22586 · DOI
  16. 10.1074/jbc.275.18.13986 · DOI
  17. 2019, Guidelines for the Detection of Nadph Oxidases by Immunoblot and Rt- qpcr, Methods Mol Biol, 1982, 191, 10.1007/978-1-4939-9424-3_12 · DOI
  18. 2019, Insights into the Nox Nadph Oxidases Using Heterologous Whole Cell Assays, Methods Mol Biol, 1982, 139, 10.1007/978-1-4939-9424-3_9 · DOI
  19. 10.1172/JCI114898 · DOI
  20. 10.1021/acschembio.5b00753 · DOI · Paper page
  21. 10.1038/ng0797-277 · DOI
  22. Gemmer, M. & Forster, F . 2020. A clearer picture of the Er translocon complex. J Cell Sci, 133. · DOI
  23. 10.1038/nprot.2014.173 · DOI
  24. 10.1016/S0022-3476(99)70299-4 · DOI
  25. 10.1042/bj2270783 · DOI
  26. 10.1002/ana.410230505 · DOI
  27. 2022, Endothelial NOX4 Oxidase Negatively Regulates Inflammation and Improves Morbidity During Influenza A Virus Lung Infection in Mice, Front Cell Infect Microbiol, 12, 883448, 10.3389/fcimb.2022.883448 · DOI
  28. 10.1111/imr.12378 · DOI · Paper page
  29. 10.1242/jcs.113241 · DOI
  30. 10.1016/j.str.2006.01.013 · DOI
  31. 10.1126/science.1660188 · DOI
  32. 10.1074/mcp.M110.002915 · DOI
  33. Leyva-Grado, V. H. , Ermler, M. E. , Schotsaert, M. , Gonzalez, M. G. , Gillespie, V. , Lim, J. K. & Garcia-Sastre, A. 2017. Contribution of the Purinergic Receptor P2X7 to Development of Lung Immunopathology during Influenza Virus Infection. mBio, 8. · DOI · Paper page
  34. 10.1038/s41586-020-2188-x · DOI · Paper page
  35. 10.1016/j.jaci.2014.04.014 · DOI
  36. 10.1038/nature17950 · DOI · Paper page
  37. 10.1038/ncb3192 · DOI · Paper page
  38. 10.1182/blood-2010-01-264218 · DOI · Paper page
  39. 10.1038/nature13152 · DOI · Paper page
  40. 10.1126/science.2848319 · DOI
  41. 10.1136/annrheumdis-2017-211287 · DOI
  42. 10.1016/j.stem.2010.03.004 · DOI · Paper page
  43. 10.1093/nar/gky1106 · DOI
  44. 10.1038/ncomms4072 · DOI
  45. 10.1016/j.freeradbiomed.2007.02.010 · DOI
  46. 10.1042/bj3150571 · DOI
  47. 10.1016/j.celrep.2017.11.054 · DOI
  48. 10.1126/science.aaz3505 · DOI
  49. 2018, Editing N-Glycan Site Occupancy with Small-Molecule Oligosaccharyltransferase Inhibitors, Cell Chem Biol, 25, 1231, 10.1016/j.chembiol.2018.07.005 · DOI
  50. 10.3389/fncel.2013.00233 · DOI
  51. 10.1111/bph.14787 · DOI
  52. 10.4049/jimmunol.1900448 · DOI
  53. 10.1183/09031936.00118414 · DOI
  54. 2017, Reactive Oxygen Species Regulate Both Priming and Established Arthritis, but with Different Mechanisms, Antioxid Redox Signal, 27, 1473, 10.1089/ars.2016.6981 · DOI
  55. 10.4049/jimmunol.0801711 · DOI
  56. 10.1038/326088a0 · DOI · Paper page
  57. 10.1146/annurev.immunol.23.021704.115653 · DOI
  58. 10.1038/316547a0 · DOI · Paper page
  59. 10.1371/journal.pone.0060792 · DOI
  60. 10.1038/sj.bjp.0707504 · DOI
  61. 10.1002/eji.200635977 · DOI
  62. 10.1073/pnas.1221385110 · DOI
  63. 10.1101/gad.184192.111 · DOI
  64. 10.1016/j.jprot.2013.10.023 · DOI
  65. 10.1016/j.imlet.2017.08.016 · DOI
  66. 2018, How the phagocyte Nadph oxidase regulates innate immunity, Free Radic Biol Med, 125, 44, 10.1016/j.freeradbiomed.2018.06.011 · DOI
  67. 2018, Eros/CYBC1 mutations: Decreased Nadph oxidase function and chronic granulomatous disease, J Allergy Clin Immunol, 143, 782
  68. 10.1084/jem.20161382 · DOI
  69. 2019, Novel endosomal NOX2 oxidase inhibitor ameliorates pandemic influenza A virus-induced lung inflammation in mice, Respirology, 24, 1011, 10.1111/resp.13524 · DOI
  70. 10.1038/s41467-017-00057-x · DOI · Paper page
  71. Tom, R. , Bisson, L. & Durocher, Y. 2008. Transfection of HEK293-EBNA1 Cells in Suspension with Linear Pei for Production of Recombinant Proteins. Csh Protoc, 2008, pdb prot4977. · DOI
  72. 2021, Pigh deficiency can be associated with severe neurodevelopmental and skeletal manifestations, Clin Genet, 99, 313, 10.1111/cge.13877 · DOI
  73. 10.1371/journal.pone.0071098 · DOI · Paper page
  74. 10.1126/science.2848318 · DOI · Paper page
  75. 10.1042/bj3210583 · DOI
  76. 10.1021/pr201135e · DOI · Paper page
  77. 2021, An epigenetic Gpi anchor defect impairs TLR4 signaling in the B cell transdifferentiation model for primary human monocytes BLaER1, Sci Rep, 11, 14983, 10.1038/s41598-021-94386-z · DOI
  78. 10.1042/bj2960557 · DOI · Paper page
  79. 10.1074/jbc.274.7.4364 · DOI
  80. 10.1074/jbc.272.43.27288 · DOI
  81. 2018, Association of NOX2 subunits genetic variants with autoimmune diseases, Free Radic Biol Med, 125, 72, 10.1016/j.freeradbiomed.2018.03.005 · DOI

Metadata

Authors
Randzavola, L. O., Mortimer, P. M., Garside, E., Dufficy, E. R., Schejtman, A., Roumelioti, G., Yu, L., Pardo, M., Spirohn, K., Tolley, C., Brandt, C., Harcourt, K., Nichols, E., Nahorski, M., Woods, G., Williamson, J. C., Suresh, S., Sowerby, J. M., Matsumoto, M., Santos, C. X. C., Kiar, C. S., Mukhopadhyay, S., Rae, W. M., Dougan, G. J., Grainger, J., Lehner, P. J., Calderwood, M., Choudhary, J., Clare, S., Speak, A., Santilli, G., Bateman, A., Smith, K. G. C., Magnani, F., & Thomas, D. C.
Affiliations
  • Imperial College London (GB)
  • University of Cambridge (GB)
  • University College London (GB)
  • Institute of Cancer Research (GB)
  • Harvard University (US)
  • Wellcome Sanger Institute (GB)
  • Kyoto Prefectural University of Medicine (JP)
  • King's College London (GB)
  • European Bioinformatics Institute (GB)
  • University of Pavia (IT)
Corresponding author
Thomas, David C.
Venue
eLife
Publisher
openRxiv
Published
2021-09-15
Volume
11
ISSN
2050-084X (ISSN-L)
OpenAlex
W4309862298
Cited by
24
References
3
Citations by year
2026: 5 · 2025: 3 · 2024: 8 · 2023: 4 · 2022: 4
FWCI
1.81
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • eLife (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (publishedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • UCL Discovery (University College London) (submittedVersion)
  • Spiral (Imperial College London) (submittedVersion, cc-by)
  • Apollo (University of Cambridge) (submittedVersion, cc-by)
  • Apollo (cc-by)
Funders
  • Wellcome Trust (104931/Z/14/Z, 104931, 210688/Z/18/Z, 206617/A/17/Z, BB/L015129/1, grant 104931/Z/14/Z, 098051, 206617/Z/17/Z)
  • Dipartimenti di Eccellenza (2018–2022)
  • National Institute for Health and Care Research (2018-2022)
  • Imperial College London (BB/L015129/1, 104931/Z/14/Z)
  • Ministero dell’Istruzione, dell’Università e della Ricerca (20182022, Dipartimenti di Eccellenza Program (2018–2022))
  • Università degli Studi di Pavia (2018-2022)
  • Medical Research Council (MR/V011561/1)
  • Biotechnology and Biological Sciences Research Council (BB/L015129/1, L015129, grant BB/L015129/1)
  • NIHR Imperial Biomedical Research Centre
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
Keywords
eros, gp91phox, NADPH oxidase, molecular chaperones, chronic granulomatous disease, purinergic signaling, P2X7 receptor, P2X1 receptor, oligosaccharyltransferase, protein glycosylation, heme incorporation, inflammasome activation, T cell response, reactive oxygen species, innate immunity, adaptive immunity
MeSH terms
Animals, Granulomatous Disease, Chronic, Humans, Phagocytes, Signal Transduction, Reactive Oxygen Species, NADPH Oxidases, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review